These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2477521)

  • 1. A method for the determination of PUVA-induced in vivo irreversible binding of 8-methoxypsoralen (8-MOP) to epidermal lipids, proteins and DNA/RNA.
    Beijersbergen van Henegouwen GM; Wijn ET; Schoonderwoerd SA; Dall'Acqua F
    J Photochem Photobiol B; 1989 Aug; 3(4):631-5. PubMed ID: 2477521
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alpha-tocopherol and di-butyl-hydroxytoluene (BHT) on UV-A-induced photobinding of 8-methoxypsoralen to Wistar rat epidermal biomacromolecules in vivo.
    Schoonderwoerd SA; Beijersbergen van Henegouwen GM; Persons KC
    Arch Toxicol; 1991; 65(6):490-4. PubMed ID: 1929870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photobinding of 8-methoxypsoralen, 4,6,4'-trimethylangelicin and chlorpromazine to Wistar rat epidermal biomacromolecules in vivo.
    Schoonderwoerd SA; Beijersbergen van Henegouwen GM; Persons CC; Caffieri S; Dall'Acqua F
    J Photochem Photobiol B; 1991 Aug; 10(3):257-68. PubMed ID: 1723425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible photobinding to skin constituents after systemic administration of chlorpromazine to Wistar rats.
    Schoonderwoerd SA; Beijersbergen van Henegouwen GM
    Photochem Photobiol; 1987 Oct; 46(4):501-5. PubMed ID: 2447597
    [No Abstract]   [Full Text] [Related]  

  • 5. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY; Gasparro FP; DeLeo VA; Santella RM
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic localization of 8-methoxypsoralen in psoriasis skin in vitro.
    Bertaux B; Dubertret L; Moreno G
    Acta Derm Venereol; 1981; 61(6):481-5. PubMed ID: 6177157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deposition of 3H-8-MOP in the eye and skin by PUVA therapy].
    Grüntzig J; Hölzle E; Holtemeyer H; von Wangenheim KH
    Fortschr Ophthalmol; 1985; 82(3):228-30. PubMed ID: 4029839
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection and quantification of 8-methoxypsoralen-DNA adducts.
    Santella RM; Yang XY; DeLeo VA; Gasparro FP
    IARC Sci Publ; 1988; (89):333-40. PubMed ID: 3058601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
    Meffert H; Metz D
    Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
    [No Abstract]   [Full Text] [Related]  

  • 10. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV radiation protecting efficacy of cysteine derivatives, studies with UVA-induced binding of 8-MOP and CPZ to rat epidermal biomacromolecules in vivo.
    Van den Broeke LT; Beijersbergen van Henegouwen GM
    Int J Radiat Biol; 1995 Apr; 67(4):411-20. PubMed ID: 7738404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long persistence of monofunctional 8-methoxypsoralen-DNA adducts in human skin in vivo.
    Ortel B; Maytum DJ; Gange RW
    Photochem Photobiol; 1991 Oct; 54(4):645-50. PubMed ID: 1796119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of DNA-psoralen photoadducts in mammalian skin.
    Pathak MA; Zarebska Z; Mihm MC; Jarzabek-Chorzelska M; Chorzelski T; Jablonska S
    J Invest Dermatol; 1986 Mar; 86(3):308-15. PubMed ID: 2427607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid.
    Lauharanta J; Juvakoski T; Kanerva L; Lassus A
    Arch Dermatol Res; 1982; 273(1-2):111-4. PubMed ID: 7184466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.
    Muret P; Humbert P; Makki S; Bechtel P; Urien S; Tillement JP
    Arch Dermatol Res; 1993; 285(5):287-90. PubMed ID: 8379689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromotography analysis of 8-methoxypsoralen monoadducts and crosslinks in lymphocytes and keratinocytes.
    Bevilacqua PM; Edelson RL; Gasparro FP
    J Invest Dermatol; 1991 Jul; 97(1):151-5. PubMed ID: 2056186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.
    Makki S; Muret P; Renaud A; Agache P; Magnin P
    J Chromatogr; 1991 Feb; 539(2):443-8. PubMed ID: 2045454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M; Hueg B; Staberg B
    Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.